deca-durabolin® 25 mg
donmed -
deca-durabolin® 50 mg
donmed -
deca durabolin 25 mg/ml solution for injection
nv organon - nandrolone decanoate - solution for injection - 25 mg/ml
deca durabolin 50 mg/ml solution for injection
nv organon - nandrolone decanoate - solution for injection - 50 mg/ml
deca durabolin 25 mg / ml solution for injection ( 25 mg/ml solution for injection
organon laboratories limited - nandrolone decanoate - solution for injection - 25 mg/ml
deca durabolin 50 mg/ml solution for injection (am 50 mg/ml solution for injection
organon laboratories limited - nandrolone decanoate - solution for injection - 50 mg/ml
deca durabolin 100mg/ml, solution for injection (a
organon laboratories limited - nandrolone decanoate - solution for injection - 100 mg/ml
deca durabolin 100mg/ml, solution for injection (a 100 mg/ml solution for injection
organon laboratories limited - nandrolone decanoate - solution for injection - 100 mg/ml
cyclosporine injection, solution
padagis us llc - cyclosporine (unii: 83hn0gtj6d) (cyclosporine - unii:83hn0gtj6d) - cyclosporine 50 mg in 1 ml - cyclosporine is indicated for the prophylaxis of organ rejection in kidney, liver, and heart allogeneic transplants. it is always to be used with adrenal corticosteroids. the drug may also be used in the treatment of chronic rejection in patients previously treated with other immunosuppressive agents. because of the risk of anaphylaxis, cyclosporine injection should be reserved for patients who are unable to take the soft gelatin capsules or oral solution. cyclosporine injection is contraindicated in patients with a hypersensitivity to cyclosporine and/or cremophor® el (polyoxyethylated castor oil).
cyclosporine injection, solution
american regent, inc. - cyclosporine (unii: 83hn0gtj6d) (cyclosporine - unii:83hn0gtj6d) - cyclosporine is indicated for the prophylaxis of organ rejection in kidney, liver, and heart allogeneic transplants. it is always to be used with adrenal corticosteroids. the drug may also be used in the treatment of chronic rejection in patients previously treated with other immunosuppressive agents. because of the risk of anaphylaxis, cyclosporine injection should be reserved for patients who are unable to take the soft gelatin capsules or oral solution. cyclosporine injection is contraindicated in patients with a hypersensitivity to cyclosporine and/or cremophor® el (polyoxyethylated castor oil).